Paul W. Maffuid

2016

In 2016, Paul W. Maffuid earned a total compensation of $481.8K as Vice President, Pharmaceutical Development and Operations at MabVax Therapeutics Holdings, a 71% decrease compared to previous year.

Compensation breakdown

Bonus$61,950
Option Awards$91,213
Salary$294,519
Other$34,121
Total$481,803

Maffuid received $294.5K in salary, accounting for 61% of the total pay in 2016.

Maffuid also received $62K in bonus, $91.2K in option awards and $34.1K in other compensation.

Rankings

In 2016, Paul W. Maffuid's compensation ranked 11,319th out of 14,075 executives tracked by ExecPay. In other words, Maffuid earned more than 19.6% of executives.

ClassificationRankingPercentile
All
11,319
out of 14,075
20th
Division
Manufacturing
4,406
out of 5,489
20th
Major group
Chemicals And Allied Products
1,577
out of 1,895
17th
Industry group
Drugs
1,274
out of 1,538
17th
Industry
Pharmaceutical Preparations
993
out of 1,176
16th
Source: SEC filing on May 2, 2017.

Maffuid's colleagues

We found three more compensation records of executives who worked with Paul W. Maffuid at MabVax Therapeutics Holdings in 2016.

2016

J Hansen

MabVax Therapeutics Holdings

Chief Executive Officer

2016

Paul Resnick

MabVax Therapeutics Holdings

Vice President, Chief Business Officer

2016

Gregory Hanson

MabVax Therapeutics Holdings

Chief Financial Officer

You may also like